Why Is UNIQURE N V (QURE) Stock Up Today?

QURE stock rose 4.64% to $49.66 on Thursday, driven by a positive gap open and sustained buying interest amid upgraded analyst ratings. The stock opened at $48.30, up 1.8% from the previous day, and climbed further to a session high of $49.80. Analyst activity in the health care sector, including upgrades and raised price targets from Wells Fargo and Wolfe Research, added momentum to the move.

What Happened

The stock’s upward movement followed a series of analyst actions that elevated investor sentiment. Wells Fargo raised its price target to $75, while Wolfe Research upgraded the stock to Outperform with a $65 price target. Barclays also maintained an Overweight rating but lowered its price target to $60. These developments occurred as the company reported a 30.2% year-to-date revenue increase, despite remaining unprofitable with a TTM EPS of -4.04. The stock’s gap open and early volatility reflected the broader market’s reaction to these developments.

What The Data Shows

The session’s volume of 0.2 million shares was in line with the 3-month average, indicating moderate participation. The stock is currently trading within its 52-week range of $8.73 to $71.50, having printed a fresh 52-week high on August 25. Over the past 8 sessions, the stock has risen 6.6%, from $44.24 to $47.16. Recent insider transactions show 19 sales totaling $16.8 million over the past 90 days, with the most recent filing on July 7. The stock’s beta of 0.94 suggests it is slightly less volatile than the broader market.

What To Watch

The stock is currently without scheduled earnings, but coverage breadth and analyst activity will remain key factors to monitor. Investors should watch for further developments from the health care sector and any follow-up from major rating firms.